PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 9372123

Alternative oxygen carriers.

J R Hess
View original source ↗Export metadata ↓

Abstract

Alternative oxygen carriers are being evaluated in human studies. Information from the clinical evaluation of these "blood substitutes" is not publicly available. Preclinical studies of solutions of modified cell-free hemoglobin and of perfluorocarbon emulsions have demonstrated significant toxicity. Hemoglobin inactivates endothelium-derived nitric oxide, participates in free-radical reactions, is a neurotoxin, activates the immune system, potentiates the effects of bacterial endotoxin, and increases the lethality of certain bacterial infections. Perfluorocarbon emulsions activate complement and cause lung dysfunction. Both materials have short intravascular half-lives. Safe doses of perfluorocarbon emulsions have very limited oxygen-carrying capacity. Protein engineering to reduce the toxicities of the modified hemoglobins is ongoing. A safe and effective erythrocyte substitute is still a distant goal.

Explore related subjects

Blood SubstitutesHumansOxygenJournal ArticleReview

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

J R Hess. 1996. Alternative oxygen carriers.. https://doi.org/10.1097/00062752-199603060-00016

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2006

Structural basis of peroxide-mediated changes in human hemoglobin: a novel oxidative pathway.

Hydrogen peroxide (H(2)O(2)) triggers a redox cycle between ferric and ferryl hemoglobin (Hb) leading to the formation of a transient protein radical and a covalent hemeprotein cross-link. Addition of H(2)O(2) to highly purified human hemoglobin (HbA(0)) induced structural changes that primarily resided within beta subunits followed by the internalization of the heme moiety within alpha subunits. These modifications were observed when an equal molar concentration of H(2)O(2) was added to HbA(0) yet became more abundant with greater concentrations of H(2)O(2). Mass spectrometric and amino acid analysis revealed for the first time that betaCys-93 and betaCys-112 were oxidized extensively and irreversibly to cysteic acid when HbA(0) was treated with H(2)O(2). Oxidation of further amino acids in HbA(0) exclusive to the beta-globin chain included modification of betaTrp-15 to oxyindolyl and kynureninyl products as well as betaMet-55 to methionine sulfoxide. These findings may therefore explain the premature collapse of the beta subunits as a result of the H(2)O(2) attack. Analysis of a tryptic digest of the main reversed phase-high pressure liquid chromatography fraction revealed two alpha-peptide fragments (alpha128-alpha139) and a heme moiety with the loss of iron, cross-linked between alphaSer-138 and the porphyrin ring. The novel oxidative pathway of HbA(0) modification detailed here may explain the diverse oxidative, toxic, and potentially immunogenic effects associated with the release of hemoglobin from red blood cells during hemolytic diseases and/or when cell-free Hb is used as a blood substitute.

Blood Substitutes↗
PubMed2006

Water solubility in linear fluoroalkanes used in blood substitute formulations.

The interactions between water and n-perfluoroalkanes or substituted alpha-(omega-)fluoroalkanes used in blood substitute formulations were investigated experimentally and using ab initio calculations. The solubility of water in C(6)-C(9) perfluoroalkanes and five C(8) analogues of substituted fluoroalkanes was measured in the temperature range between 288 and 318 K at atmospheric pressure, using a Karl Fischer coulometer. From these data, the thermodynamic functions and partial molar solvation quantities such as Gibbs energy, enthalpy, and entropy were determined and compared with the interaction energies in 1:1 water-fluoroalkane complexes in vacuum, obtained using B3LYP/6-311++G(d,p). The experimental solubility data indicates a significant specific interaction between the water and the alpha-(omega-)substitute atom (H, I, Br, or Cl) in the fluoroalkanes.

Blood Substitutes↗